Aminoacidopathy

Gene: GLS

Green List (high evidence)

GLS (glutaminase)
EnsemblGeneIds (GRCh38): ENSG00000115419
EnsemblGeneIds (GRCh37): ENSG00000115419
OMIM: 138280, ClinGen, DECIPHER
GLS is in 7 panels

3 reviews

Lucy Spencer (Victorian Clinical Genetics Services)

I don't know

PMID: 37151363 has a 2nd case report for the dominant condition. A 4yo boy with epilepsy and developmental delay and strongly increased concentrations of glutamate and decreased glutamine in the brain. Noted to NOT have cataracts. De novo for NM_014905.4: c.1382A > T; p.(His461Leu) absent from gnomad.

PMID: 35803560: report a 3rd de novo missense in this gene NM_014905(GLS):c.866A > T (p.Lys289Ile). However this patient died at seven years of age with severe, progressive spastic quadriplegia, vasculitic skin rash since infancy and a
heterogeneous white matter signal abnormality with diffuse atrophy on MRI. This paper notes that the original proband in PMID: 30239721 also had a vasculitic rash (described as dermatological abnormalities in the original paper). The original proband is also noted as having "profound axial hypotonia leading to kyphoscoliosis" and "uncontrolled motoric agitation and self-injurious behavior."

Still amber for the dominant condition, limited by ClinGen for this

CASGID syndrome MIM#618339
Created: 21 Nov 2025, 4:44 p.m. | Last Modified: 21 Nov 2025, 4:44 p.m.
Panel Version: 1.3634

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
CASGID syndrome MIM#618339

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

DEFINITIVE for bi-allelic disease by ClinGen. LIMITED for mono-allelic.
Created: 8 Aug 2024, 7:25 a.m. | Last Modified: 8 Aug 2024, 7:25 a.m.
Panel Version: 1.128

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Glutaminase deficiency MONDO:0600001; Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development MONDO:0032685

Sangavi Sivagnanasundram (Melbourne Health)

I don't know

Classified as Moderate by ClinGen Aminoacidopathy GCEP on 26/07/2024 - https://search.clinicalgenome.org/CCID:004966

Two unrelated probands have been reported with an increased glutamate production level. Two missense variants have been reported (Ser482Cys and His461Leu - both absent from gnomAD v4.1). A zebrafish model partially recapitulated the disease.
Created: 5 Aug 2024, 10:14 a.m. | Last Modified: 5 Aug 2024, 10:14 a.m.
Panel Version: 1.128
Classified Definitive by ClinGen Aminoacidopathy GCEP on 09/07/2021 - https://search.clinicalgenome.org/CCID:004965

6 probands have been reported with glutaminase deficiency. Nonsense, framshift and missense variants have been reported. 5’UTR repeat expansion (680-1500 repeats; normal range 8-16 repeats) has also been reported.
Mouse model was also conducted that recapitulates the human phenotype (PMID: 16641247).
Sources: ClinGen
Created: 5 Jun 2024, 5:49 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development MONDO:0032685

Publications

Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

Details

Mode of Inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • ClinGen
Phenotypes
  • Glutaminase deficiency MONDO:0600001
  • Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development MONDO:0032685
OMIM
138280
ClinGen
GLS
DECIPHER
GLS
Clinvar variants
Variants in GLS
Penetrance
None
Publications
Panels with this gene

History Filter Activity

8 Aug 2024, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: GLS were set to 29468182; 30575854; 30970188; 16641247; 30239721, 37151363

8 Aug 2024, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: GLS were changed from glutaminase deficiency MONDO:0600001 to Glutaminase deficiency MONDO:0600001; Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development MONDO:0032685

8 Aug 2024, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: GLS were set to 29468182, 30575854, 30970188; 16641247

8 Aug 2024, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: GLS was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

7 Jun 2024, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: gls has been classified as Green List (High Evidence).

7 Jun 2024, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: gls has been classified as Green List (High Evidence).

5 Jun 2024, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Sangavi Sivagnanasundram (Melbourne Health)

gene: GLS was added gene: GLS was added to Aminoacidopathy. Sources: ClinGen Mode of inheritance for gene: GLS was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: GLS were set to 29468182, 30575854, 30970188; 16641247 Phenotypes for gene: GLS were set to glutaminase deficiency MONDO:0600001 Review for gene: GLS was set to GREEN